Grigori Ermakov

Statistics

Publications

Citations

335

H-Index

Active since

2014

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Grigori Ermakov is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, antibody structure, and antibody-antigen recognition.

Publications per year

2014–2023

Publications

Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

Peter Orth, Li Xiao, Lorraine D. Hernandez et al. · Journal of Biological Chemistry · 2014 · 138 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells

Selvakumar Sukumar, Douglas C. Wilson, Ying Yu et al. · Cancer Research · 2017 · 63 citations

Life Sciences, Immunology, Oncology +17

Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab

Lorraine D. Hernandez, Heather K. Kroh, Edward J. Hsieh et al. · Journal of Molecular Biology · 2017 · 42 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo

Xiaoyu Yang, Fengqiang Wang, Ying Zhang et al. · Journal of Pharmaceutical Sciences · 2015 · 39 citations

Pharmacy, Immunology, Oncology +13

Epitope mapping of monoclonal antibodies: a comprehensive comparison of different technologies

Xibei Dang, Lars Guelen, D. Lutje Hulsik et al. · mAbs · 2023 · 36 citations · Full text

Pharmacy, Immunology, Pharmacology +17

1–5 of 6